Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ImmunoPrecise Antibodies Q3 2025 GAAP EPS C$(0.66) May Not Be Comparable To C$(0.08) Estimate, Sales C$6.15M Miss C$6.58M Estimate

Author: Benzinga Newsdesk | March 28, 2025 08:05am
ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly losses of $(0.66) per share which missed the analyst consensus estimate of $(0.08) by 725 percent. This is a 725 percent decrease over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $6.15 million which missed the analyst consensus estimate of $6.58 million by 6.59 percent. This is a 1.13 percent decrease over sales of $6.22 million the same period last year.

Posted In: IPA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist